Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R4ML
|
|||
| Former ID |
DIB002049
|
|||
| Drug Name |
P1A
|
|||
| Synonyms |
IPSAT P1A; P1A, Ipsat Therapies
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Toxicity [ICD-11: N.A.] | Discontinued in Phase 2 | [1] | |
| Company |
Ipsat Therapies Oy
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H44O6
|
|||
| Canonical SMILES |
CC(C)CCC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O
|
|||
| InChI |
1S/C27H44O6/c1-15(2)6-7-23(31)26(5,32)22-9-11-27(33)17-12-19(28)18-13-20(29)21(30)14-24(18,3)16(17)8-10-25(22,27)4/h12,15-16,18,20-23,29-33H,6-11,13-14H2,1-5H3/t16-,18-,20+,21-,22-,23+,24+,25+,26+,27+/m0/s1
|
|||
| InChIKey |
PJYYBCXMCWDUAZ-JJJZTNILSA-N
|
|||
| CAS Number |
CAS 13408-56-5
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:28135
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Staphylococcus Beta-lactamase (Stap-coc blaZ) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020134) | |||
| REF 2 | IPSAT P1A, a class A beta-lactamase therapy for the prevention of penicillin-induced disruption to the intestinal microflora. Curr Opin Investig Drugs. 2009 Aug;10(8):838-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.